EUROPE HEPARIN MARKET ANALYSIS

Europe Heparin Market, by Product Type (Low Molecular Weight Heparin, Unfractionated Heparin, Ultra Low Molecular Weight Heparin), by End User (Hospitals, Blood and Stem Cell Bank, Others (Laboratories, Acute Care Centers)) and by Country (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) -

Published In : Jul 2023
Code : CMI3960
Pages :199
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Europe Heparin Market- Regional Analysis

Among country, U.K. is the fastest-growing segment in the Europe heparin market over the forecast period. According to an article published in Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions, on August 29, 2022, explained pretreatment with unfractionated heparin was associated with a reduction in coronary artery occlusion among patients with segment elevation myocardial infarction, with a number needed to treat (NNT) of 12, without increasing the risk of major in-hospital bleeding. Regarding mortality, a reduction was found with unfractionated heparin pretreatment, with an NNT of 94, but this effect was not robust over all sensitivity analyses and residual confounding cannot be excluded.